Release Details

WILMINGTON, Del.--(BUSINESS WIRE)--Jan. 17, 2025-- The Chemours Company (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours’ Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250117002959/en/

Damián Gumpel, President of Chemours’ Titanium Technologies (TT) business segment, effective March 3, 2025. (Photo: Business Wire)

“After a comprehensive global search, Damián Gumpel was the clear choice to lead our Titanium Technologies business into the future. Damián’s proven track record of strategic vision, cost transformation, and commercial excellence within the chemical industry will strengthen the TT business,” said Denise Dignam, President and CEO of Chemours. “I am confident that under Damián’s leadership, our TT business will continue building on the success of the TT Transformation Plan and contribute significantly to Chemours’ Pathway to Thrive strategy."

Damián Gumpel joins Chemours with deep chemical industry leadership experience. At the Olin Corporation, he most recently served as Vice President, Corporate Strategy, helping to define a new corporate strategy and executing a joint venture and several M&A transactions. Previously, he led Olin’s global leading Epoxy business, where he delivered cost reductions and successfully executed a portfolio realignment, and Olin’s Chlor Alkali Products and Vinyls business, where he led a business transformation that delivered record EBITDA improvement. At Dow Inc., he held several business leadership roles within Dow’s leading chlor-alkali and vinyls business.

“I am honored to lead Chemours Titanium Technologies, one of the most trusted and respected TiO₂ businesses in the world,” said Gumpel. “Together, we will drive stronger operational performance and productivity while deepening Chemours’ reputation as a safe and great place to work for employees, trusted partner to our customers, suppliers and communities, and consistent value driver for shareholders.”

Chemours also announces that Matthew Abbott, Senior Vice President and Chief Enterprise Transformation Officer, has elected to leave the company to pursue a new opportunity, effective February 3, 2025.

“We thank Matt for his eight years of service, including stepping up as Interim Chief Financial Officer for Chemours last year. Matt served with the highest levels of integrity and partnership at an important inflection point for our company. For that, and his many lasting contributions to our business, we thank him and wish him well in his future endeavors,” said Denise Dignam.

With Abbott’s departure, Ms. Picho will now lead the newly organized Enterprise Enablement unit designed to accelerate the Operational Excellence and Growth Enablement pillars of Chemours’ Pathway to Thrive strategy. Her portfolio will include Procurement and key Centers of Excellence, including Manufacturing, Commercial, and Digital, with a mandate to improve Chemours’ Order to Cash and critical operational processes across the company. Ms. Picho brings over 40 years of business leadership spanning each of Chemours’ three business segments.

“Diane has long been one of the most trusted and admired executives at Chemours, with a comprehensive understanding of our company that will be an immense asset to the Chemours Executive Team. Her leadership of the Enterprise Enablement unit will be a key driver to realizing our full potential as Chemours,” said Dignam.

About The Chemours Company
The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,100 employees and 28 manufacturing sites and serves approximately 2,700 customers in approximately 110 countries.

For more information, visit chemours.com or follow us on X (formerly Twitter) @Chemours or LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the impact of individual expertise on overall company performance, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250117002959/en/

INVESTORS
Brandon Ontjes
VP, Head of Strategy & Investor Relations
+1.302.773.3300
investor@chemours.com

NEWS MEDIA
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com

Source: The Chemours Company